Solid Biosciences Inc (SLDB)
10.18
-0.06
(-0.63%)
USD |
NASDAQ |
May 03, 16:00
10.18
0.00 (0.00%)
After-Hours: 19:10
Solid Biosciences Total Liabilities (Quarterly): 38.46M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.46M |
| September 30, 2023 | 40.37M |
| June 30, 2023 | 40.99M |
| March 31, 2023 | 45.80M |
| December 31, 2022 | 48.59M |
| September 30, 2022 | 41.20M |
| June 30, 2022 | 46.26M |
| March 31, 2022 | 22.04M |
| December 31, 2021 | 24.17M |
| September 30, 2021 | 25.62M |
| June 30, 2021 | 27.92M |
| March 31, 2021 | 32.28M |
| December 31, 2020 | 39.08M |
| September 30, 2020 | 18.29M |
| Date | Value |
|---|---|
| June 30, 2020 | 17.25M |
| March 31, 2020 | 17.50M |
| December 31, 2019 | 23.42M |
| September 30, 2019 | 22.40M |
| June 30, 2019 | 19.81M |
| March 31, 2019 | 21.12M |
| December 31, 2018 | 14.41M |
| September 30, 2018 | 11.74M |
| June 30, 2018 | 9.178M |
| March 31, 2018 | 10.29M |
| December 31, 2017 | 135.45M |
| September 30, 2017 | 11.85M |
| December 31, 2016 | 78.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.25M
Minimum
Jun 2020
48.59M
Maximum
Dec 2022
31.13M
Average
27.92M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 2.263B |
| PTC Therapeutics Inc | 2.684B |
| Capricor Therapeutics Inc | 36.13M |
| Perspective Therapeutics Inc | 22.71M |
| Electromed Inc | 6.622M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.94M |
| Shareholders Equity (Quarterly) | 126.48M |